Metabolic Syndrome Associated with Subclinical Hypothyroidism and Vit D Insufficiency - A Case Report and Discussion

Main Article Content

A. S. V. Prasad

Abstract

Metabolic syndrome (MetS) associated with hypothyroidism, was reported in literature. Like-wise association between hypothyroidism and Vit. D deficiency was reported. Hypothyroidism, Vit. D deficiency in DM2 patients was also reported, in the literature. But the occurrence of MetS, hypothyroidism and Vit. D deficiency, together occurring in a case was unreported. The author presented such triple association in a male patient aged 54 years. While Met S itself was a risk factor for CVD (cardiovascular vascular disease) and so were independently, the hypothyroidism and hypovitaminosis D, the triple association would have cumulative risk for CVD. So, it would be  profitable  to screen all MetS cases with hypothyroidism, for Vit. D deficiency also, in view of the possible cumulative risk. Literature was reviewed as to the relationship of MetS to hypothyroidism and Vit D deficiency, as well as the changing diagnostic criteria of MetS and it’s pathogenesis.

Keywords:
Metabolic syndrome, hypothyroidism, vitamin D, insulin resistance, central obesity, dyslipidaemias.

Article Details

How to Cite
Prasad, A. S. V. (2019). Metabolic Syndrome Associated with Subclinical Hypothyroidism and Vit D Insufficiency - A Case Report and Discussion. Asian Journal of Case Reports in Medicine and Health, 2(3), 1-9. Retrieved from http://journalajcrmh.com/index.php/AJCRMH/article/view/30109
Section
Case Report

References

Hallar H Gesamte. Epidermiology and associated risk factors of hyperlipoproteinemi Inn Med. 1977;32(8): 124-8.

Zimmet P, et al. The metabolic syndrome: A global public health problem and a new definition. Atheroscle Thromb; 2005.

Alberti KG, et al. Harmonizing the metabolic syndrome: A joint interim statement of the International Federation of Diabetes , Task Force on Epidemiology and prevention; National Heart, Lungs and Blood Institute; American Heart Association , World Heart Federation; International Atherosclerosis Society, and the International Association for the study of Obesity . Circulation; 2007.

Eiji Oda. Metabolic syndrome: Its history, mechanisms, and limitations. Acta Diabetologicavoume. 2012;49(2):89–95.

Meher LK, Raveendranathan SK, Kota SK, Sarangi J, Jali SN. Prevalence of hypothyroidism in patients with metabolic syndrome. Thyroid Res Pract. 2013;10:60–4.

Gyawali P, Takanche JS, Shrestha RK, Bhattarai P, Khanal K, Risal P, et al. Pattern of thyroid dysfunction in patients with metabolic syndrome and its relationship with components of metabolic syndrome. Diabetes Metab J. 2015;39(1):66–73.

Waring AC, Rodondi N, Harrison S, Kanaya AM, Simonsick EM, Miljkovic I, et al. Thyroid function and prevalent and incident metabolic syndrome in older adults: The health, aging, and body composition study. Clin End ocrinol (Oxf). 2012;76(6):911–8.

Park SB, Choi HC, Joo NS. The relation of thyroid function to components of the metabolic syndrome in Korean Men and Women. J Korean Med Sci. 2011;26(4): 540–5.

Garduño-Garcia Jde J, Alvirde-Garcia U, López-Carrasco G, Padilla Mendoza ME, Mehta R, Arellano-Campos O, et al. TSH and free thyroxine concentrations are associated with differing metabolic markers in euthyroid subjects. Eur J Endocrinol. 2010;163(2):273–88.

Kc R, Khatiwada S, Deo Mehta K, Pandey P, Lamsal M, Majhi S. Cardiovascular risk factors in subclinical hypothyroidism: A case control study in Nepalese population. J Thyroid Res. 2015;305241.

Udenze I, Nnaji I, Oshodi T. Thyroid function in adult Nigerians with metabolic syndrome. Pan Afr Med J. 2014;18: 352.

Tarcin O, Abanonu GB, Yazici D, Tarcin O. Association of metabolic syndrome parameters with TT3 and FT3/FT4 ratio in obese Turkish population. Metab Syndr (1-3) Disord. 2012;10(2):137–42.

Canaris GJ, Manowitz NR, Mayor G, Ridgway EC. The Colorado thyroid disease 4 study. Arch Intern Med. 2000;160:526–34.

De Bruin TW, van Barlingen H, van Linde-Sibenius Trip M, van Vuurst de Vries AR, Akveld MJ, Erkelens DW. Lipoprotein(a) and apolipoprotein B plasma concentrations in hypothyroid, euthyroid, and hyperthyroid subjects. J Clin EndocrinolMetab. 1993;76:121–614.

Klausen IC, Nielsen FE, Hegedus L, Gerdes LU, Charles P, Faergeman O. Treatment of hypothyroidism reduces low-density lipoproteins but not lipoprotein (a) Metabolism. 1992;41:911–4.

Danese MD, Powe NR, Sawin CT, Ladenson PW. Screening for mild thyroid failure at the periodic health examination: a decision and cost-effectiveness analysis. JAMA. 1996;276:285–92.

Meher LK, Raveendranathan SK, Kota SK, Sarangi J, Jali SN. Prevalence of hypothyroidism in patients with metabolic syndrome. Thyroid Res Pract. 2013;10:60–4.

Bakker OF, Meijssen S, Wiersinga WM. Effects of triiodothyronine and amiodarone on the promoter of the human LDL receptor gene. Biochem Biophys Res Commun. 1998;249:517–21.

Shin DJ, Osborne TF. Thyroid hormone regulation and cholesterol metabolism are connected through Sterol Regulatory Element-Binding Protein-2 (SREBP-2). J Biol Chem. 2003;278:34114–8.
[PubMed] [Google Scholar]

Faure P, Oziol L, Artur Y, Chomard P. Thyroid hormone (T3) and its acetic derivative (TA3) protect low-density lipoproteins from oxidation by different mechanisms. Biochimie. 2004;86:411–8.
[PubMed] [Google Scholar]

Lagrost L. Regulation of cholesteryl ester transfer protein (CETP) activity: Review of in vitro and in vivo studies. Biochim Biophys Acta. 1994;1215:209–36. HbA1C. Anantarapu 8, et al. Effects of thyroid hormone replacement on glycated he n non-diabetic subjects with overt hypothyroidism. Arch Endocrinol Metab. September 25 2015 [Epub ahead of print].

Santamarina-Fojo S, Gonzalez-Navarro H, Freeman L, Wagner E, Nong Z. Hepatic lipase, lipoprotein metabolism, and atherogenesis. Arterioscler Thromb Vasc Biol. 2004;24:1750–4.

Prieur X, Huby T, Coste H, Schaap FG, Chapman MJ, Rodriguez JC. Thyroid hormone regulates the hypotriglyceridemic gene APOA5. J Biol Chem. 2005;280: 27533–43.

Rensen PC, Van Dijk KW, Havekes LM. Apolipoprotein AV. Low concentration, high impact. Arterioscler Thromb Vasc Biol. 2005;25:2445–7.

Anantarapu S, et al. Effects of thyroid hormone replacement on glycated he n non-diabetic subjects with overt hypothyroidism. Arch Endocrinol Metab; 2015.

Chiu KC, Chu A, Go VL, Saad MF. Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction. Am J ClinNutr. 2004;79:820–825. Vit D. & hypothyroidism.

Tamer G, Arik S, Tamer I, Coksert D. Relative vitamin D insufficiency in Hashimoto's thyroiditis. Thyroid. 2011;21: 891–6.

Mackawy AM, Al-Ayed BM, Al-Rashidi BM. Vitamin d deficiency and its association with thyroid disease. Int J Health Sci (Qassim). 2013;7:267–75.

Wang TJ, Pencina MJ, Booth SL, Jacques PF, Ingelsson E, Lanier K, Benjamin EJ, DÁgostino RB, Wolf M, Vasan RS. Vitamin D deficiency and cardio vascular disease. Circulation. 2008;117:503–511. DOI:10.1161/CIRCULATIONAHA.107.706127

Cheng S, Massaro JM, Fox CS, Larson MG, Keyes MJ, McCabe EL, Robins SJ, O’Donnell CJ, Hoffmann U, Jacques PF, et al. Adiposity, cardiometabolic risk, and vitamin D status: The Framingham Heart Study. Diabetes. 2010;59:242–248.

Abdulbari Bener. The impact of Vitamin D deficiency on retinopathy and hearing loss among type diabetic patients. Biomed Research International; 2018.

Parker J, Hashmi O, Dutton D, Mavrodaris A, Stranges S, Kandala NB, Clarke A, Franco OH. Levels of Vitamin D and cardiometabolic disorders: systematic review and meta-analysis. Maturitas. 2010; 65:225–236.
DOI: 10.1001/archinte.167.11.1159

Lee JH, O’Keefe JH, Bell D, Hensrud DD, Holick MF. Vitamin D deficiency: An important, common, and easily treatable cardiovascular risk factor? J. Am. Coll. Cardiol. 2008;52:1949–1956.

e38-e48 Circulation. 2016;1331(4).

Barbarawi M, et al. Vitamin D supplementation and cardiovascular disease risks in more than 83 000 individuals in 21 randomized clinical trials: A Meta-analysis. JAMA Cardiol; 2019.